Information  X 
Enter a valid email address

Fed Rep Nigeria (78UT)

  Print      Mail a friend

Wednesday 21 February, 2018

Fed Rep Nigeria

Publication of Final Terms

RNS Number : 5676F
Federal Republic of Nigeria (The)
21 February 2018
 

Publication of Final Terms

The following final terms (the "Final Terms") are available for viewing:

1.   Final Terms in relation to the issue of U.S.$1,250,000,000 7.143 per cent. Notes due 2030 by the Federal Republic of Nigeria (the "Issuer") under the Issuer's Global Medium Term Note Programme (the "Programme")

2.   Final Terms in relation to the issue of U.S.$1,250,000,000 7.696 per cent. Notes due 2038 by the issuer under the Programme

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/5676F_-2018-2-21.pdf

http://www.rns-pdf.londonstockexchange.com/rns/5676F_1-2018-2-21.pdf

For further information, please contact: [email protected]

DISCLAIMER - INTENDED ADDRESSEES

The Final Terms referred to above must be read in conjunction with the base prospectus dated 21 November 2017 as supplemented by the prospectus supplement dated 15 February 2018 in respect of the Programme (the "Base Prospectus") for the purposes of the Prospectus Directive (Directive 2003/71/EC, as amended).

 

Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and/or Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and/or Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and/or Base Prospectus you must ascertain from the Final Terms and Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

In particular, the Final Terms does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to in the Final Terms have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act, and the rules and regulations thereunder. The Issuer does not intend to register any of the securities referred to in the Final Terms in the United States or to conduct a public offering of the securities referred to in the Final Terms in the United States or elsewhere.

 

The Final Terms has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Final Terms made available to you in electronic format and the hard copy version available to you on request from the Issuer.

 

Your right to access this service is conditional upon complying with the above requirement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTUAVVRWOAUUAR

a d v e r t i s e m e n t